Indian Pharma major, Alembic Pharmaceuticals informed the bourses on Wednesday that its joint venture, Aleor Dermaceuticals Limited received tentative approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Testosterone gel, 1.62 per cent.

Leading global Fintech solutions provider, Infibeam Avenues Limited announced its collaboration with Bank Muscat, Oman's biggest Bank, in a move aimed to offer payment processing services under the flagship brand CCAvenue to merchants in Oman. This would also give a boost to the e-commerce sector in the region.

A leading global pure-play engineering services company, L&T Technology Services informed the exchanges on Friday that it has been selected as a Consulting and Professional Services (CPS) provider to support Amazon Alexa Voice Service (AVS) integration in various connected devices spanning multiple domains and industries.

Leading product engineering and digital transformation services provider, Sasken Technologies announced that it partnered with Tunisia‐based Primatec Engineering, a specialist in the testing and validation of automotive electronic control units.

Shares of Titan Company were trading closer to its 52-week high on Thursday after the company announced that it saw good performances across all its businesses in the festive season.

Shares of budget airline, SpiceJet were up by almost 13 per cent on Thursday after the US Federal Aviation Administration (FAA) cleared the Boeing 737 Max for flight after two-years of grounding.

On Friday, Natco Pharma announced that its marketing partner, Breckenridge Pharmaceutical Inc., has received final approval for its abbreviated new drug application (ANDA) for Pomalidomide capsules, from United States Food & Drug Administration (USFDA).

Dr Reddy’s Laboratories informed the exchanges after trading hours on Thursday that it has launched Succinylcholine Chloride injection USP, 200 mg/10 ml (20 mg/ml), multiple-dose vials in the US markets.

ONGC Videsh Limited (OVL) announced on Wednesday about its entry in Senegalese offshore after signing a definitive binding agreement with Australia’s FAR Limited.

Glenmark Pharma informed the bourses today before the market hours that it has received final approval from United States Food & Drug Administration (USFDA) for Tacrolimus capsules USP, 0.5 mg, 1 mg & 5 mg, the generic version of Prograf 1 capsules, 0.5 mg, 1 mg & 5 mg of Astellas Pharma.